This is inconsistent with the theory of a subclone of CML evolving into PTCL as one would expect that such clonal evolution resulted in a cell that continued to bear t(9;22) and express BCR-ABL1. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.